Reading Time: 3 minutesIntroduction Prader-Willi Syndrome (PWS) is a complex genetic disorder that presents significant challenges in managing growth, metabolism, and behavior. Among the therapeutic options available, Genotropin, a recombinant human growth hormone, has been utilized to address some of the growth and metabolic issues associated with PWS. This article delves into a decade-long study examining the efficacy of Genotropin in American males with PWS, offering insights into its long-term benefits and limitations. Overview of Prader-Willi Syndrome Prader-Willi Syndrome is characterized by hypotonia in infancy, followed by hyperphagia leading to obesity, short stature, hypogonadism, and various cognitive and behavioral issues. The syndrome's impact … Continue reading →